Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PLoS Genet ; 8(5): e1002721, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22654673

RESUMO

In both humans and Drosophila melanogaster, UDP-galactose 4'-epimerase (GALE) catalyzes two distinct reactions, interconverting UDP-galactose (UDP-gal) and UDP-glucose (UDP-glc) in the final step of the Leloir pathway of galactose metabolism, and also interconverting UDP-N-acetylgalactosamine (UDP-galNAc) and UDP-N-acetylglucosamine (UDP-glcNAc). All four of these UDP-sugars serve as vital substrates for glycosylation in metazoans. Partial loss of GALE in humans results in the spectrum disorder epimerase deficiency galactosemia; partial loss of GALE in Drosophila melanogaster also results in galactose-sensitivity, and complete loss in Drosophila is embryonic lethal. However, whether these outcomes in both humans and flies result from loss of one GALE activity, the other, or both has remained unknown. To address this question, we uncoupled the two activities in a Drosophila model, effectively replacing the endogenous dGALE with prokaryotic transgenes, one of which (Escherichia coli GALE) efficiently interconverts only UDP-gal/UDP-glc, and the other of which (Plesiomonas shigelloides wbgU) efficiently interconverts only UDP-galNAc/UDP-glcNAc. Our results demonstrate that both UDP-gal and UDP-galNAc activities of dGALE are required for Drosophila survival, although distinct roles for each activity can be seen in specific windows of developmental time or in response to a galactose challenge. By extension, these data also suggest that both activities might play distinct and essential roles in humans.


Assuntos
Drosophila melanogaster/genética , Drosophila melanogaster/metabolismo , UDPglucose 4-Epimerase/genética , UDPglucose 4-Epimerase/metabolismo , Animais , Animais Geneticamente Modificados , Drosophila melanogaster/enzimologia , Escherichia coli/genética , Feminino , Fertilidade/genética , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Plesiomonas/genética , UDPglucose 4-Epimerase/deficiência , Uridina Difosfato Galactose/metabolismo , Uridina Difosfato Glucose/metabolismo , Uridina Difosfato N-Acetilgalactosamina/metabolismo , Uridina Difosfato N-Acetilglicosamina/metabolismo
2.
Biochem Biophys Res Commun ; 399(4): 537-41, 2010 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-20678478

RESUMO

SeSAME syndrome is a complex disease characterized by seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance. Mutations in the inwardly rectifying potassium channel Kir4.1 (KCNJ10 gene) have been linked to this condition. Kir4.1 channels are weakly rectifying channels expressed in glia, kidney, cochlea and possibly other tissues. We determined the electrophysiological properties of SeSAME mutant channels after expression in transfected mammalian cells. We found that a majority of mutations (R297C, C140R, R199X, T164I) resulted in complete loss of Kir4.1 channel function while two mutations (R65P and A167V) produced partial loss of function. All mutant channels were rescued upon co-transfection of wild-type Kir4.1 but not Kir5.1 channels. Cell-surface biotinylation assays indicate significant plasma membrane expression of all mutant channels with exception of the non-sense mutant R199X. These results indicate the differential loss of Kir channel function among SeSAME syndrome mutations.


Assuntos
Ataxia/metabolismo , Perda Auditiva Neurossensorial/metabolismo , Deficiência Intelectual/metabolismo , Canais de Potássio Corretores do Fluxo de Internalização/metabolismo , Convulsões/metabolismo , Desequilíbrio Hidroeletrolítico/metabolismo , Animais , Ataxia/genética , Biotinilação , Linhagem Celular , Perda Auditiva Neurossensorial/genética , Humanos , Deficiência Intelectual/genética , Mutação , Canais de Potássio Corretores do Fluxo de Internalização/genética , Ratos , Convulsões/genética , Síndrome , Desequilíbrio Hidroeletrolítico/genética
3.
Dis Model Mech ; 6(1): 84-94, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22773758

RESUMO

Classic galactosemia is a genetic disorder that results from profound loss of galactose-1P-uridylyltransferase (GALT). Affected infants experience a rapid escalation of potentially lethal acute symptoms following exposure to milk. Dietary restriction of galactose prevents or resolves the acute sequelae; however, many patients experience profound long-term complications. Despite decades of research, the mechanisms that underlie pathophysiology in classic galactosemia remain unclear. Recently, we developed a Drosophila melanogaster model of classic galactosemia and demonstrated that, like patients, GALT-null Drosophila succumb in development if exposed to galactose but live if maintained on a galactose-restricted diet. Prior models of experimental galactosemia have implicated a possible association between galactose exposure and oxidative stress. Here we describe application of our fly genetic model of galactosemia to the question of whether oxidative stress contributes to the acute galactose sensitivity of GALT-null animals. Our first approach tested the impact of pro- and antioxidant food supplements on the survival of GALT-null and control larvae. We observed a clear pattern: the oxidants paraquat and DMSO each had a negative impact on the survival of mutant but not control animals exposed to galactose, and the antioxidants vitamin C and α-mangostin each had the opposite effect. Biochemical markers also confirmed that galactose and paraquat synergistically increased oxidative stress on all cohorts tested but, interestingly, the mutant animals showed a decreased response relative to controls. Finally, we tested the expression levels of two transcripts responsive to oxidative stress, GSTD6 and GSTE7, in mutant and control larvae exposed to galactose and found that both genes were induced, one by more than 40-fold. Combined, these results implicate oxidative stress and response as contributing factors in the acute galactose sensitivity of GALT-null Drosophila and, by extension, suggest that reactive oxygen species might also contribute to the acute pathophysiology in classic galactosemia.


Assuntos
Galactosemias/genética , Galactosemias/metabolismo , Animais , Antioxidantes/farmacologia , Ácido Ascórbico/farmacologia , Cisteína/metabolismo , Dimetil Sulfóxido/toxicidade , Modelos Animais de Doenças , Proteínas de Drosophila/deficiência , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/efeitos dos fármacos , Drosophila melanogaster/enzimologia , Drosophila melanogaster/genética , Galactose/metabolismo , Galactose/toxicidade , Galactosemias/tratamento farmacológico , Galactosemias/etiologia , Galactosefosfatos/metabolismo , Expressão Gênica/efeitos dos fármacos , Técnicas de Inativação de Genes , Genes de Insetos , Glutationa/metabolismo , Glutationa Transferase/genética , Glutationa Transferase/metabolismo , Humanos , Mutação , Estresse Oxidativo/efeitos dos fármacos , Paraquat/toxicidade , Espécies Reativas de Oxigênio/metabolismo , UDPglucose-Hexose-1-Fosfato Uridiltransferase/deficiência , UDPglucose-Hexose-1-Fosfato Uridiltransferase/genética , Xantonas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA